Tsivgoulis, G. Katsanos, A.H. Mavridis, D. Grigoriadis, N. Dardiotis, E. Heliopoulos, I. Papathanasopoulos, P. Karapanayiotides, T. Kilidireas, C. Hadjigeorgiou, G.M. Voumvourakis, K. Gravanis, A. Papadimitriou, A. Rompos, A. Mouzaki, A. Kylintireas, C. Voumvourakis, C. Karagogeos, D. Hadjigeorgiou, G. Kollias, G. Helliopoulos, I. Probert, L. Ioannidis, P. Pelidou, S.-E. Tzartos, S. Karapanagiotides, T. Panoutsakopoulou, V. HELANI (Hellenic Academy of Neuroimmunology), The efficacy of Natalizumab versus Fingolimod for patients with relapsing-remitting multiple sclerosis: A systematic review, indirect evidence from randomized placebo-controlled trials and meta-analysis of observational head-to-head trials, PLOS ONE, (11), 2016, Public Library of Science,